PPT-Withdrawal of pharmacological therapy for heart failure in recovered dilated cardiomyopathy

Withdrawal of pharmacological therapy for heart failure in recovered dilated cardiomyopathy a randomised trial TREDHF Brian P Halliday MBChB PhD On behalf of Sanjay K Prasad PI John GF Cleland coPI. Dilated cardiomyopathy is a disease characteriz ed by enlargement of all four heart cham bers The walls of the ventricles are abnormally thin and the heart has a severely reduced ability to contract Cats with dilated cardiomyopathy usually have cong Gender differences and similarities. Lynette W. . Lissin. , MD FACC. Palo Alto Medical Foundation. April 21, 2012. Goals. Epidemiology and types of heart failure. Differences in incidence, clinical characteristics, prognosis in women vs. men. Michelle A. Hart MD CCFP . M.Sc.C.H. . Sid Feldman MD CCFP FCFP. Baycrest Health Sciences, Toronto, ON. Department of Family and Community Medicine,. University of Toronto. Faculty/Presenter Disclosure. What Role does genetics play?. . April 1. st. , 2013. Heart Failure Education Series. David N.. Edwards, M.D. Ph.D. F.A.C.C.. Advanced Heart Care, PA. The Heart Hospital Baylor Plano. Family History. C. ontrolled Trials: a workshop. Ngaire. . Kerse. Professor and General Practitioner and asker of questions. . Key issues - . randomised. trials. There must be uncertainty. The question m. ust be answerable and feasible. Appraisal. “Frequency and Prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial”. Group. . 8. Case Illustration. A Couple, Men . and women . , 55 yo want to travel with economy . Randomised trials face many challenges including slow or suboptimal recruitment;. Across trials, it is estimated that less than 50% meet their recruitment target or do so only with an extension to the original trial duration;. Study day November 2015Overview and IntroductionThis course is an introduction and overview of heart failure Normal heart function and basic pathophysiologyof heart failure is explained This will be DEFINITION AND CLASSIFICATION. C. ardiomyopathies . are defined as “disorders characterized by morphologically and functionally abnormal myocardium in the absence of any other disease that is sufficient, by itself, to cause the observed phenotype.”. in the Molecular Motors. that . Power . the Heart. Myosin Molecular . Motor. David M. Warshaw, Ph.D.. Molecular Physiology & Biophysics. Hank Gathers. Reggie Lewis. Genetic Defects in Myosin Motor. Akash Srinivasan. as14317@ic.ac.uk. Shortness of Breath. Heart Failure. Cardiomyopathy. . . Constrictive pericarditis. Myocarditis. Shortness of Breath. Poor removal of CO2. . . Poor delivery of oxygen. Page 1 Rev 2 .0 Patient Information Non - Ischemic Cardiomyopathy almutairi. . Assistant professor internal . medicin. dept. . (MBBS)(SBMD). CONTENET. Introduction. Epidemiology. Pathophysiology. syst. olic/. diast. olic. Risk factors. Signs and symptoms. Classification of HF severity. , MD, MHA. Consultant Heart Failure & Transplantation. Heart failure is an enormous medical and societal burden . More than 2% of the U.S. population, or almost 5 million people, are affected,. It consumes approximately 2% of the National Health Service budget in the United Kingdom, and in the United States, .